Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of
cancer-related death. Early detection of prostate cancer is largely determined by a widely …

Bone metastasis is the leading cause of death in prostate cancer patients, for which there is
currently no effective treatment. Since the bone microenvironment plays an important role in …

The role of tumor-associated macrophages (TAMs), along with the regulatory mechanisms
underlying distinct macrophage activation states, remains poorly understood in prostate …

Metastasis is the major cause of treatment failure in cancer patients and of cancer-related
deaths. This editorial discusses how cancer metastasis may be better perceived and …

Background Inflammation‐based indexes have been used to predict survival and recurrence
in cancer patients. Systemic immune‐inflammation index (SII) was reported to be associated …

Increasing reports on epidemiological, diagnostic, and clinical studies suggest that
dysfunction of the inflammatory reaction results in chronic illnesses such as cancer, arthritis …

Tumor‐infiltrating immune cells play a crucial role in tumor progression and response to
treatment. However, the limited studies on infiltrating immune cells have shown inconsistent …

Purpose: It was reported that the novel preoperative systemic immune-inflammation index
(SII) can predict survival in cases of many malignant tumors. However, the prognostic …

Abstract Purpose of Review Despite significant progress, patients with metastatic prostate
cancer continue to have poor prognosis. Immunotherapy has revolutionized cancer care for …

Prostate cancer and prostatitis are both significant health concerns. A large number of
studies have established that the occurrence of the two is closely related. However, the most …